Borst P, Elferink RO: Mammalian ABC transporters in health and disease. Annu Rev Biochem. 2002, 71: 537-592. 10.1146/annurev.biochem.71.102301.093055.
Article
CAS
PubMed
Google Scholar
WHO: World Malaria Report 2012. 2012, Geneva: World Health Organization
Google Scholar
Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ: Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009, 361: 455-467. 10.1056/NEJMoa0808859.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hayeshi R, Masimirembwa C, Mukanganyama S, Ungell AL: The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux. Eur J Pharm Sci. 2006, 29: 70-81. 10.1016/j.ejps.2006.05.009.
Article
CAS
PubMed
Google Scholar
Riffkin CD, Chung R, Wall DM, Zalcberg JR, Cowman AF, Foley M, Tilley L: Modulation of the function of human MDR1 P-glycoprotein by the antimalarial drug mefloquine. Biochem Pharmacol. 1996, 52: 1545-1552. 10.1016/S0006-2952(96)00556-4.
Article
CAS
PubMed
Google Scholar
Crowe A, Ilett KF, Karunajeewa HA, Batty KT, Davis TM: Role of P glycoprotein in absorption of novel antimalarial drugs. Antimicrob Agents Chemother. 2006, 50: 3504-3506. 10.1128/AAC.00708-06.
Article
PubMed Central
CAS
PubMed
Google Scholar
Burk O, Arnold KA, Nussler AK, Schaeffeler E, Efimova E, Avery BA, Avery MA, Fromm MF, Eichelbaum M: Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. Mol Pharmacol. 2005, 67: 1954-1965. 10.1124/mol.104.009019.
Article
CAS
PubMed
Google Scholar
Solary E, Velay I, Chauffert B, Bidan JM, Caillot D, Dumas M, Guy H: Sufficient levels of quinine in the serum circumvent the multidrug resistance of the human leukemic cell line K562/ADM. Cancer. 1991, 68: 1714-1719. 10.1002/1097-0142(19911015)68:8<1714::AID-CNCR2820680811>3.0.CO;2-2.
Article
CAS
PubMed
Google Scholar
Lehnert M, Dalton WS, Roe D, Emerson S, Salmon SE: Synergistic inhibition by verapamil and quinine of P-glycoprotein-mediated multidrug resistance in a human myeloma cell line model. Blood. 1991, 77: 348-354.
CAS
PubMed
Google Scholar
Vezmar M, Georges E: Direct binding of chloroquine to the multidrug resistance protein (MRP): possible role for MRP in chloroquine drug transport and resistance in tumor cells. Biochem Pharmacol. 1998, 56: 733-742. 10.1016/S0006-2952(98)00217-2.
Article
CAS
PubMed
Google Scholar
Stark M, Rothem L, Jansen G, Scheffer GL, Goldman ID, Assaraf YG: Antifolate resistance associated with loss of MRP1 expression and function in Chinese hamster ovary cells with markedly impaired export of folate and cholate. Mol Pharmacol. 2003, 64: 220-227. 10.1124/mol.64.2.220.
Article
CAS
PubMed
Google Scholar
Efferth T, Olbrich A, Bauer R: mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether. Biochem Pharmacol. 2002, 64: 617-623. 10.1016/S0006-2952(02)01221-2.
Article
CAS
PubMed
Google Scholar
Bram E, Ifergan I, Shafran A, Berman B, Jansen G, Assaraf YG: Mutant Gly482 and Thr482 ABCG2 mediate high-level resistance to lipophilic antifolates. Cancer Chemother Pharmacol. 2006, 58: 826-834. 10.1007/s00280-006-0230-9.
Article
CAS
PubMed
Google Scholar
WHO: Global Update on HIV Treatment 2013: Results, Impact and Opportunities. 2013, Geneva: World Health Organization
Google Scholar
El-Sheikh AA, van den Heuvel JJ, Koenderink JB, Russel FG: Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2- and MRP4/ABCC4-mediated methotrexate transport. J Pharmacol Exp Ther. 2007, 320: 229-235.
Article
CAS
PubMed
Google Scholar
Wittgen HG, van den Heuvel JJ, van den Broek PH, Dinter-Heidorn H, Koenderink JB, Russel FG: Cannabinoid type 1 receptor antagonists modulate transport activity of multidrug resistance-associated proteins MRP1, MRP2, MRP3, and MRP4. Drug Metab Dispos. 2011, 39: 1294-1302. 10.1124/dmd.110.037812.
Article
CAS
PubMed
Google Scholar
Gozalpour E, Wittgen HG, van den Heuvel JJ, Greupink R, Russel FG, Koenderink JB: Interaction of digitalis-like compounds with p-glycoprotein. Toxicol Sci. 2013, 131: 502-511. 10.1093/toxsci/kfs307.
Article
CAS
PubMed
Google Scholar
Dankers AC, Sweep FC, Pertijs JC, Verweij V, van den Heuvel JJ, Koenderink JB, Russel FG, Masereeuw R: Localization of breast cancer resistance protein (Bcrp) in endocrine organs and inhibition of its transport activity by steroid hormones. Cell Tissue Res. 2012, 349: 551-563. 10.1007/s00441-012-1417-5.
Article
PubMed Central
CAS
PubMed
Google Scholar
van Beusekom CD, van den Heuvel JJ, Koenderink JB, Schrickx JA, Russel FG: The feline bile salt export pump: a structural and functional comparison with canine and human Bsep/BSEP. BMC Vet Res. 2013, 9: 259-10.1186/1746-6148-9-259.
Article
PubMed Central
PubMed
Google Scholar
Van Aubel RA, Koenderink JB, Peters JG, Van Os CH, Russel FG: Mechanisms and interaction of vinblastine and reduced glutathione transport in membrane vesicles by the rabbit multidrug resistance protein Mrp2 expressed in insect cells. Mol Pharmacol. 1999, 56: 714-719.
CAS
PubMed
Google Scholar
Thapar MM, Ashton M, Lindegardh N, Bergqvist Y, Nivelius S, Johansson I, Bjorkman A: Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (Malarone) when taken as chemoprophylaxis. Eur J Clin Pharmacol. 2002, 58: 19-27. 10.1007/s00228-002-0426-9.
Article
CAS
PubMed
Google Scholar
Lalloo DG, Hill DR: Preventing malaria in travellers. BMJ. 2008, 336: 1362-1366. 10.1136/bmj.a153.
Article
PubMed Central
PubMed
Google Scholar
Huls M, Brown CD, Windass AS, Sayer R, van den Heuvel JJ, Heemskerk S, Russel FG, Masereeuw R: The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. Kidney Int. 2008, 73: 220-225. 10.1038/sj.ki.5002645.
Article
CAS
PubMed
Google Scholar
Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH, van De Vijver MJ, Scheper RJ, Schellens JH: Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 2001, 61: 3458-3464.
CAS
PubMed
Google Scholar
Rolan PE, Mercer AJ, Tate E, Benjamin I, Posner J: Disposition of atovaquone in humans. Antimicrob Agents Chemother. 1997, 41: 1319-1321.
PubMed Central
CAS
PubMed
Google Scholar
Ngo LY, Yogev R, Dankner WM, Hughes WT, Burchett S, Xu J, Sadler B, Unadkat JD: Pharmacokinetics of azithromycin administered alone and with atovaquone in human immunodeficiency virus-infected children. The ACTG 254 Team. Antimicrob Agents Chemother. 1999, 43: 1516-1519.
PubMed Central
CAS
PubMed
Google Scholar
Tommasi C, Bellagamba R, Tempestilli M, D'Avolio A, Gallo AL, Ivanovic J, Nicastri E, Pucillo LP, Narciso P: Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis. Malar J. 2011, 10: 141-10.1186/1475-2875-10-141.
Article
PubMed Central
CAS
PubMed
Google Scholar
Gupta A, Zhang Y, Unadkat JD, Mao Q: HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2). J Pharmacol Exp Ther. 2004, 310: 334-341. 10.1124/jpet.104.065342.
Article
CAS
PubMed
Google Scholar
Zembruski NC, Haefeli WE, Weiss J: Interaction potential of etravirine with drug transporters assessed in vitro. Antimicrob Agents Chemother. 2011, 55: 1282-1284. 10.1128/AAC.01527-10.
Article
PubMed Central
CAS
PubMed
Google Scholar
Zembruski NC, Buchel G, Jodicke L, Herzog M, Haefeli WE, Weiss J: Potential of novel antiretrovirals to modulate expression and function of drug transporters in vitro. J Antimicrob Chemother. 2011, 66: 802-812. 10.1093/jac/dkq501.
Article
CAS
PubMed
Google Scholar
Lu AH, Shu Y, Huang SL, Wang W, Ou-Yang DS, Zhou HH: In vitro proguanil activation to cycloguanil is mediated by CYP2C19 and CYP3A4 in adult Chinese liver microsomes. Acta Pharmacol Sin. 2000, 21: 747-752.
CAS
PubMed
Google Scholar
Eagling VA, Back DJ, Barry MG: Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir. Br J Clin Pharmacol. 1997, 44: 190-194.
Article
PubMed Central
CAS
PubMed
Google Scholar
Scholler-Gyure M, Kakuda TN, Raoof A, De Smedt G, Hoetelmans RM: Clinical pharmacokinetics and pharmacodynamics of etravirine. Clin Pharmacokinet. 2009, 48: 561-574. 10.2165/10895940-000000000-00000.
Article
CAS
PubMed
Google Scholar
Cocohoba J, Dong BJ: Raltegravir: the first HIV integrase inhibitor. Clin Ther. 2008, 30: 1747-1765. 10.1016/j.clinthera.2008.10.012.
Article
CAS
PubMed
Google Scholar
Abel S, Russell D, Taylor-Worth RJ, Ridgway CE, Muirhead GJ: Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers. Br J Clin Pharmacol. 2008, 65 (Suppl 1): 27-37.
Article
PubMed Central
CAS
PubMed
Google Scholar
van Luin M, Van der Ende ME, Richter C, Visser M, Faraj D, Van der Ven A, Gelinck L, Kroon F, Wit FW, Van Schaik RH, Kuks PF, Burger DM: Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir. AIDS. 2010, 24: 1223-1226. 10.1097/QAD.0b013e3283389129.
Article
CAS
PubMed
Google Scholar
Weiss J, Rose J, Storch CH, Ketabi-Kiyanvash N, Sauer A, Haefeli WE, Efferth T: Modulation of human BCRP (ABCG2) activity by anti-HIV drugs. J Antimicrob Chemother. 2007, 59: 238-245.
Article
CAS
PubMed
Google Scholar
Merino G, Alvarez AI, Pulido MM, Molina AJ, Schinkel AH, Prieto JG: Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion. Drug Metab Dispos. 2006, 34: 690-695. 10.1124/dmd.105.008219.
Article
CAS
PubMed
Google Scholar
Burger H, van Tol H, Boersma AW, Brok M, Wiemer EA, Stoter G, Nooter K: Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump. Blood. 2004, 104: 2940-2942. 10.1182/blood-2004-04-1398.
Article
CAS
PubMed
Google Scholar
Elkind NB, Szentpetery Z, Apati A, Ozvegy-Laczka C, Varady G, Ujhelly O, Szabo K, Homolya L, Varadi A, Buday L, Kéri G, Német K, Sarkadi B: Multidrug transporter ABCG2 prevents tumor cell death induced by the epidermal growth factor receptor inhibitor Iressa (ZD1839, Gefitinib). Cancer Res. 2005, 65: 1770-1777. 10.1158/0008-5472.CAN-04-3303.
Article
CAS
PubMed
Google Scholar
Brendel C, Scharenberg C, Dohse M, Robey RW, Bates SE, Shukla S, Ambudkar SV, Wang Y, Wennemuth G, Burchert A, Boudriot U, Neubauer A: Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells. Leukemia. 2007, 21: 1267-1275. 10.1038/sj.leu.2404638.
Article
CAS
PubMed
Google Scholar
Chen ZS, Robey RW, Belinsky MG, Shchaveleva I, Ren XQ, Sugimoto Y, Ross DD, Bates SE, Kruh GD: Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport. Cancer Res. 2003, 63: 4048-4054.
CAS
PubMed
Google Scholar
Matsushima S, Maeda K, Kondo C, Hirano M, Sasaki M, Suzuki H, Sugiyama Y: Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein. J Pharmacol Exp Ther. 2005, 314: 1059-1067. 10.1124/jpet.105.085589.
Article
CAS
PubMed
Google Scholar
Maliepaard M, van Gastelen MA, Tohgo A, Hausheer FH, van Waardenburg RC, de Jong LA, Pluim D, Beijnen JH, Schellens JH: Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918. Clin Cancer Res. 2001, 7: 935-941.
CAS
PubMed
Google Scholar
Borgnia MJ, Eytan GD, Assaraf YG: Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity. J Biol Chem. 1996, 271: 3163-3171. 10.1074/jbc.271.6.3163.
Article
CAS
PubMed
Google Scholar
van der Sandt IC, Blom-Roosemalen MC, de Boer AG, Breimer DD: Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines. Eur J Pharm Sci. 2000, 11: 207-214. 10.1016/S0928-0987(00)00097-X.
Article
CAS
PubMed
Google Scholar
Wang EJ, Casciano CN, Clement RP, Johnson WW: Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors. Biochem Biophys Res Commun. 2001, 289: 580-585. 10.1006/bbrc.2001.6000.
Article
CAS
PubMed
Google Scholar
Nagy H, Goda K, Fenyvesi F, Bacso Z, Szilasi M, Kappelmayer J, Lustyik G, Cianfriglia M, Szabo G: Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies. Biochem Biophys Res Commun. 2004, 315: 942-949. 10.1016/j.bbrc.2004.01.156.
Article
CAS
PubMed
Google Scholar
Pukrittayakamee S, Prakongpan S, Wanwimolruk S, Clemens R, Looareesuwan S, White NJ: Adverse effect of rifampin on quinine efficacy in uncomplicated falciparum malaria. Antimicrob Agents Chemother. 2003, 47: 1509-1513. 10.1128/AAC.47.5.1509-1513.2003.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hedman A, Angelin B, Arvidsson A, Dahlqvist R, Nilsson B: Interactions in the renal and biliary elimination of digoxin: stereoselective difference between quinine and quinidine. Clin Pharmacol Ther. 1990, 47: 20-26. 10.1038/clpt.1990.3.
Article
CAS
PubMed
Google Scholar
Soyinka JO, Onyeji CO, Omoruyi SI, Owolabi AR, Sarma PV, Cook JM: Pharmacokinetic interactions between ritonavir and quinine in healthy volunteers following concurrent administration. Br J Clin Pharmacol. 2010, 69: 262-270. 10.1111/j.1365-2125.2009.03566.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Choo EF, Leake B, Wandel C, Imamura H, Wood AJ, Wilkinson GR, Kim RB: Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes. Drug Metab Dispos. 2000, 28: 655-660.
CAS
PubMed
Google Scholar
Yamazaki M, Neway WE, Ohe T, Chen I, Rowe JF, Hochman JH, Chiba M, Lin JH: In vitro substrate identification studies for p-glycoprotein-mediated transport: species difference and predictability of in vivo results. J Pharmacol Exp Ther. 2001, 296: 723-735.
CAS
PubMed
Google Scholar
Soyinka JO, Onyeji CO, Omoruyi SI, Owolabi AR, Sarma PV, Cook JM: Effects of concurrent administration of nevirapine on the disposition of quinine in healthy volunteers. J Pharm Pharmacol. 2009, 61: 439-443. 10.1211/jpp.61.04.0004.
Article
PubMed Central
CAS
PubMed
Google Scholar
Uriel A, Lewthwaite P: Malaria therapy in HIV: drug interactions between nevirapine and quinine. Int J STD AIDS. 2011, 22: 768-10.1258/ijsa.2009.009489.
Article
CAS
PubMed
Google Scholar
Nyunt MM, Lu Y, El-Gasim M, Parsons TL, Petty BG, Hendrix CW: Effects of ritonavir-boosted lopinavir on the pharmacokinetics of quinine. Clin Pharmacol Ther. 2012, 91: 889-895. 10.1038/clpt.2011.326.
Article
CAS
PubMed
Google Scholar
Fardel O, Lecureur V, Loyer P, Guillouzo A: Rifampicin enhances anti-cancer drug accumulation and activity in multidrug-resistant cells. Biochem Pharmacol. 1995, 49: 1255-1260. 10.1016/0006-2952(95)00045-2.
Article
CAS
PubMed
Google Scholar
Collett A, Tanianis-Hughes J, Hallifax D, Warhurst G: Predicting P-glycoprotein effects on oral absorption: correlation of transport in Caco-2 with drug pharmacokinetics in wild-type and mdr1a(-/-) mice in vivo. Pharm Res. 2004, 21: 819-826.
Article
CAS
PubMed
Google Scholar
Geick A, Eichelbaum M, Burk O: Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem. 2001, 276: 14581-14587. 10.1074/jbc.M010173200.
Article
CAS
PubMed
Google Scholar
Yeka A, Achan J, D'Alessandro U, Talisuna AO: Quinine monotherapy for treating uncomplicated malaria in the era of artemisinin-based combination therapy: an appropriate public health policy?. Lancet Infect Dis. 2009, 9: 448-452. 10.1016/S1473-3099(09)70109-4.
Article
CAS
PubMed
Google Scholar
WHO: Guidelines for the Treatment of Malaria. 2010, Geneva: World Health Organization
Google Scholar
Taylor WR, White NJ: Antimalarial drug toxicity: a review. Drug Saf. 2004, 27: 25-61.
Article
CAS
PubMed
Google Scholar